A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Elarekibep in Healthy Japanese Subjects

Clinical trial NCT05794672 · TERMINATED

Trial details

NCT number: NCT05794672
Sponsor: AstraZeneca
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects (Indication: Asthma)

Start date: 2023-04-11
Primary completion: 2023-07-08
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.